nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—SLC6A4—chronic obstructive pulmonary disease	0.184	0.565	CbGaD
Aripiprazole—HTR2A—chronic obstructive pulmonary disease	0.141	0.435	CbGaD
Aripiprazole—ADRB1—Salbutamol—chronic obstructive pulmonary disease	0.065	0.158	CbGbCtD
Aripiprazole—CHRM5—Tiotropium—chronic obstructive pulmonary disease	0.0598	0.146	CbGbCtD
Aripiprazole—ADRB1—Formoterol—chronic obstructive pulmonary disease	0.0492	0.12	CbGbCtD
Aripiprazole—ADRB1—Arformoterol—chronic obstructive pulmonary disease	0.0492	0.12	CbGbCtD
Aripiprazole—CHRM3—Tiotropium—chronic obstructive pulmonary disease	0.0382	0.0931	CbGbCtD
Aripiprazole—CHRM1—Tiotropium—chronic obstructive pulmonary disease	0.0332	0.081	CbGbCtD
Aripiprazole—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.0307	0.0747	CbGbCtD
Aripiprazole—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0125	0.0306	CbGbCtD
Aripiprazole—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0125	0.0306	CbGbCtD
Aripiprazole—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0112	0.0272	CbGbCtD
Aripiprazole—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0105	0.0256	CbGbCtD
Aripiprazole—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00711	0.0173	CbGbCtD
Aripiprazole—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00678	0.0165	CbGbCtD
Aripiprazole—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00604	0.0147	CbGbCtD
Aripiprazole—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.00592	0.0144	CbGbCtD
Aripiprazole—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00559	0.0136	CbGbCtD
Aripiprazole—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.00483	0.181	CbGeAlD
Aripiprazole—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00355	0.00864	CbGbCtD
Aripiprazole—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00335	0.00816	CbGbCtD
Aripiprazole—HTR7—pulmonary artery—chronic obstructive pulmonary disease	0.00281	0.105	CbGeAlD
Aripiprazole—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.00175	0.0656	CbGeAlD
Aripiprazole—Cilostazol—CYP1A2—chronic obstructive pulmonary disease	0.000929	0.239	CrCbGaD
Aripiprazole—Vilazodone—SLC6A4—chronic obstructive pulmonary disease	0.000867	0.223	CrCbGaD
Aripiprazole—H1F0—respiratory system—chronic obstructive pulmonary disease	0.000767	0.0287	CbGeAlD
Aripiprazole—HTR3A—respiratory system—chronic obstructive pulmonary disease	0.000731	0.0273	CbGeAlD
Aripiprazole—H1F0—connective tissue—chronic obstructive pulmonary disease	0.000675	0.0252	CbGeAlD
Aripiprazole—H1F0—bronchus—chronic obstructive pulmonary disease	0.000631	0.0236	CbGeAlD
Aripiprazole—H1F0—smooth muscle tissue—chronic obstructive pulmonary disease	0.000618	0.0231	CbGeAlD
Aripiprazole—H1F0—trachea—chronic obstructive pulmonary disease	0.000567	0.0212	CbGeAlD
Aripiprazole—SLC6A4—respiratory system—chronic obstructive pulmonary disease	0.000558	0.0208	CbGeAlD
Aripiprazole—HTR1D—connective tissue—chronic obstructive pulmonary disease	0.000523	0.0195	CbGeAlD
Aripiprazole—ADRB1—connective tissue—chronic obstructive pulmonary disease	0.000508	0.019	CbGeAlD
Aripiprazole—ADRB1—bronchus—chronic obstructive pulmonary disease	0.000475	0.0178	CbGeAlD
Aripiprazole—HTR7—respiratory system—chronic obstructive pulmonary disease	0.000473	0.0177	CbGeAlD
Aripiprazole—DRD2—respiratory system—chronic obstructive pulmonary disease	0.000447	0.0167	CbGeAlD
Aripiprazole—HTR2B—smooth muscle tissue—chronic obstructive pulmonary disease	0.000445	0.0166	CbGeAlD
Aripiprazole—HTR7—connective tissue—chronic obstructive pulmonary disease	0.000417	0.0156	CbGeAlD
Aripiprazole—CHRM1—trachea—chronic obstructive pulmonary disease	0.000411	0.0153	CbGeAlD
Aripiprazole—H1F0—lung—chronic obstructive pulmonary disease	0.000407	0.0152	CbGeAlD
Aripiprazole—CHRM3—smooth muscle tissue—chronic obstructive pulmonary disease	0.0004	0.015	CbGeAlD
Aripiprazole—HTR3A—lung—chronic obstructive pulmonary disease	0.000388	0.0145	CbGeAlD
Aripiprazole—HTR7—smooth muscle tissue—chronic obstructive pulmonary disease	0.000381	0.0142	CbGeAlD
Aripiprazole—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.000364	0.0136	CbGeAlD
Aripiprazole—ADRA2C—bronchus—chronic obstructive pulmonary disease	0.000358	0.0134	CbGeAlD
Aripiprazole—HRH1—respiratory system—chronic obstructive pulmonary disease	0.000353	0.0132	CbGeAlD
Aripiprazole—HTR7—trachea—chronic obstructive pulmonary disease	0.00035	0.0131	CbGeAlD
Aripiprazole—Ziprasidone—SLC6A4—chronic obstructive pulmonary disease	0.000328	0.0844	CrCbGaD
Aripiprazole—ADRA2C—trachea—chronic obstructive pulmonary disease	0.000321	0.012	CbGeAlD
Aripiprazole—HRH1—connective tissue—chronic obstructive pulmonary disease	0.000311	0.0116	CbGeAlD
Aripiprazole—ADRB1—lung—chronic obstructive pulmonary disease	0.000307	0.0115	CbGeAlD
Aripiprazole—ADRA2A—connective tissue—chronic obstructive pulmonary disease	0.000305	0.0114	CbGeAlD
Aripiprazole—Ziprasidone—CYP1A2—chronic obstructive pulmonary disease	0.000299	0.0769	CrCbGaD
Aripiprazole—SLC6A4—lung—chronic obstructive pulmonary disease	0.000296	0.0111	CbGeAlD
Aripiprazole—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000295	0.011	CbGeAlD
Aripiprazole—CHRM1—lung—chronic obstructive pulmonary disease	0.000295	0.011	CbGeAlD
Aripiprazole—HTR2B—lung—chronic obstructive pulmonary disease	0.000293	0.011	CbGeAlD
Aripiprazole—ADRA2A—bronchus—chronic obstructive pulmonary disease	0.000286	0.0107	CbGeAlD
Aripiprazole—HRH1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000285	0.0106	CbGeAlD
Aripiprazole—Nefazodone—SLC6A4—chronic obstructive pulmonary disease	0.000276	0.0709	CrCbGaD
Aripiprazole—HRH1—trachea—chronic obstructive pulmonary disease	0.000261	0.00976	CbGeAlD
Aripiprazole—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.00026	0.00971	CbGeAlD
Aripiprazole—ADRA2A—trachea—chronic obstructive pulmonary disease	0.000256	0.00959	CbGeAlD
Aripiprazole—Trazodone—SLC6A4—chronic obstructive pulmonary disease	0.000255	0.0656	CrCbGaD
Aripiprazole—Ziprasidone—HTR2A—chronic obstructive pulmonary disease	0.000252	0.0649	CrCbGaD
Aripiprazole—HTR7—lung—chronic obstructive pulmonary disease	0.000251	0.00939	CbGeAlD
Aripiprazole—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000238	0.00888	CbGeAlD
Aripiprazole—DRD2—lung—chronic obstructive pulmonary disease	0.000238	0.00888	CbGeAlD
Aripiprazole—ADRA2C—lung—chronic obstructive pulmonary disease	0.000231	0.00863	CbGeAlD
Aripiprazole—HTR2A—trachea—chronic obstructive pulmonary disease	0.000218	0.00815	CbGeAlD
Aripiprazole—Nefazodone—HTR2A—chronic obstructive pulmonary disease	0.000212	0.0545	CrCbGaD
Aripiprazole—Trazodone—HTR2A—chronic obstructive pulmonary disease	0.000196	0.0505	CrCbGaD
Aripiprazole—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000193	0.00723	CbGeAlD
Aripiprazole—CYP3A5—lung—chronic obstructive pulmonary disease	0.000193	0.00723	CbGeAlD
Aripiprazole—HRH1—lung—chronic obstructive pulmonary disease	0.000188	0.00701	CbGeAlD
Aripiprazole—ADRA2A—lung—chronic obstructive pulmonary disease	0.000184	0.00689	CbGeAlD
Aripiprazole—HTR2A—lung—chronic obstructive pulmonary disease	0.000157	0.00586	CbGeAlD
Aripiprazole—Perphenazine—CYP1A2—chronic obstructive pulmonary disease	0.000149	0.0383	CrCbGaD
Aripiprazole—ABCB1—trachea—chronic obstructive pulmonary disease	0.000143	0.00534	CbGeAlD
Aripiprazole—Perphenazine—HTR2A—chronic obstructive pulmonary disease	0.000126	0.0323	CrCbGaD
Aripiprazole—ABCB1—lung—chronic obstructive pulmonary disease	0.000103	0.00384	CbGeAlD
Aripiprazole—Infection—Salbutamol—chronic obstructive pulmonary disease	7.37e-05	0.00046	CcSEcCtD
Aripiprazole—Hypotension—Arformoterol—chronic obstructive pulmonary disease	7.34e-05	0.000458	CcSEcCtD
Aripiprazole—Hypotension—Formoterol—chronic obstructive pulmonary disease	7.34e-05	0.000458	CcSEcCtD
Aripiprazole—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	7.34e-05	0.000457	CcSEcCtD
Aripiprazole—Pruritus—Aminophylline—chronic obstructive pulmonary disease	7.31e-05	0.000455	CcSEcCtD
Aripiprazole—Shock—Salbutamol—chronic obstructive pulmonary disease	7.3e-05	0.000455	CcSEcCtD
Aripiprazole—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	7.28e-05	0.000454	CcSEcCtD
Aripiprazole—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	7.27e-05	0.000453	CcSEcCtD
Aripiprazole—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	7.24e-05	0.000451	CcSEcCtD
Aripiprazole—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	7.24e-05	0.000451	CcSEcCtD
Aripiprazole—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	7.21e-05	0.000449	CcSEcCtD
Aripiprazole—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	7.18e-05	0.000447	CcSEcCtD
Aripiprazole—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	7.17e-05	0.000447	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	7.16e-05	0.000446	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	7.16e-05	0.000446	CcSEcCtD
Aripiprazole—Insomnia—Formoterol—chronic obstructive pulmonary disease	7.11e-05	0.000443	CcSEcCtD
Aripiprazole—Insomnia—Arformoterol—chronic obstructive pulmonary disease	7.11e-05	0.000443	CcSEcCtD
Aripiprazole—Anorexia—Salbutamol—chronic obstructive pulmonary disease	7.07e-05	0.000441	CcSEcCtD
Aripiprazole—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	7.07e-05	0.00044	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	7.01e-05	0.000437	CcSEcCtD
Aripiprazole—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	7.01e-05	0.000437	CcSEcCtD
Aripiprazole—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	7.01e-05	0.000437	CcSEcCtD
Aripiprazole—Somnolence—Formoterol—chronic obstructive pulmonary disease	6.99e-05	0.000435	CcSEcCtD
Aripiprazole—Somnolence—Arformoterol—chronic obstructive pulmonary disease	6.99e-05	0.000435	CcSEcCtD
Aripiprazole—Insomnia—Montelukast—chronic obstructive pulmonary disease	6.96e-05	0.000434	CcSEcCtD
Aripiprazole—Hypotension—Salbutamol—chronic obstructive pulmonary disease	6.93e-05	0.000432	CcSEcCtD
Aripiprazole—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	6.92e-05	0.000431	CcSEcCtD
Aripiprazole—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	6.92e-05	0.000431	CcSEcCtD
Aripiprazole—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	6.91e-05	0.000431	CcSEcCtD
Aripiprazole—Pruritus—Tiotropium—chronic obstructive pulmonary disease	6.89e-05	0.000429	CcSEcCtD
Aripiprazole—Injury—Prednisone—chronic obstructive pulmonary disease	6.85e-05	0.000427	CcSEcCtD
Aripiprazole—Somnolence—Montelukast—chronic obstructive pulmonary disease	6.84e-05	0.000427	CcSEcCtD
Aripiprazole—Dizziness—Aminophylline—chronic obstructive pulmonary disease	6.83e-05	0.000426	CcSEcCtD
Aripiprazole—Weight increased—Prednisolone—chronic obstructive pulmonary disease	6.81e-05	0.000425	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	6.79e-05	0.000423	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	6.79e-05	0.000423	CcSEcCtD
Aripiprazole—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	6.78e-05	0.000422	CcSEcCtD
Aripiprazole—Fatigue—Arformoterol—chronic obstructive pulmonary disease	6.78e-05	0.000422	CcSEcCtD
Aripiprazole—Fatigue—Formoterol—chronic obstructive pulmonary disease	6.78e-05	0.000422	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	6.76e-05	0.000421	CcSEcCtD
Aripiprazole—Constipation—Arformoterol—chronic obstructive pulmonary disease	6.72e-05	0.000419	CcSEcCtD
Aripiprazole—Pain—Arformoterol—chronic obstructive pulmonary disease	6.72e-05	0.000419	CcSEcCtD
Aripiprazole—Pain—Formoterol—chronic obstructive pulmonary disease	6.72e-05	0.000419	CcSEcCtD
Aripiprazole—Constipation—Formoterol—chronic obstructive pulmonary disease	6.72e-05	0.000419	CcSEcCtD
Aripiprazole—Insomnia—Salbutamol—chronic obstructive pulmonary disease	6.71e-05	0.000418	CcSEcCtD
Aripiprazole—Amnesia—Prednisone—chronic obstructive pulmonary disease	6.7e-05	0.000417	CcSEcCtD
Aripiprazole—Increased appetite—Prednisone—chronic obstructive pulmonary disease	6.7e-05	0.000417	CcSEcCtD
Aripiprazole—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	6.66e-05	0.000415	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	6.65e-05	0.000414	CcSEcCtD
Aripiprazole—Fatigue—Montelukast—chronic obstructive pulmonary disease	6.64e-05	0.000414	CcSEcCtD
Aripiprazole—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	6.62e-05	0.000412	CcSEcCtD
Aripiprazole—Somnolence—Salbutamol—chronic obstructive pulmonary disease	6.6e-05	0.000411	CcSEcCtD
Aripiprazole—Pain—Montelukast—chronic obstructive pulmonary disease	6.58e-05	0.00041	CcSEcCtD
Aripiprazole—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	6.58e-05	0.00041	CcSEcCtD
Aripiprazole—Vomiting—Aminophylline—chronic obstructive pulmonary disease	6.57e-05	0.000409	CcSEcCtD
Aripiprazole—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	6.54e-05	0.000408	CcSEcCtD
Aripiprazole—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	6.54e-05	0.000408	CcSEcCtD
Aripiprazole—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	6.53e-05	0.000407	CcSEcCtD
Aripiprazole—Purpura—Prednisone—chronic obstructive pulmonary disease	6.53e-05	0.000407	CcSEcCtD
Aripiprazole—Rash—Aminophylline—chronic obstructive pulmonary disease	6.51e-05	0.000406	CcSEcCtD
Aripiprazole—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	6.51e-05	0.000405	CcSEcCtD
Aripiprazole—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	6.49e-05	0.000404	CcSEcCtD
Aripiprazole—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	6.48e-05	0.000404	CcSEcCtD
Aripiprazole—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	6.48e-05	0.000404	CcSEcCtD
Aripiprazole—Headache—Aminophylline—chronic obstructive pulmonary disease	6.47e-05	0.000403	CcSEcCtD
Aripiprazole—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	6.45e-05	0.000402	CcSEcCtD
Aripiprazole—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	6.45e-05	0.000402	CcSEcCtD
Aripiprazole—Dizziness—Tiotropium—chronic obstructive pulmonary disease	6.44e-05	0.000401	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	6.43e-05	0.000401	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	6.43e-05	0.000401	CcSEcCtD
Aripiprazole—Lethargy—Prednisone—chronic obstructive pulmonary disease	6.42e-05	0.0004	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	6.41e-05	0.000399	CcSEcCtD
Aripiprazole—Fatigue—Salbutamol—chronic obstructive pulmonary disease	6.4e-05	0.000399	CcSEcCtD
Aripiprazole—Pain—Salbutamol—chronic obstructive pulmonary disease	6.35e-05	0.000396	CcSEcCtD
Aripiprazole—Constipation—Salbutamol—chronic obstructive pulmonary disease	6.35e-05	0.000396	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	6.3e-05	0.000392	CcSEcCtD
Aripiprazole—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	6.29e-05	0.000392	CcSEcCtD
Aripiprazole—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	6.29e-05	0.000392	CcSEcCtD
Aripiprazole—Urticaria—Arformoterol—chronic obstructive pulmonary disease	6.24e-05	0.000389	CcSEcCtD
Aripiprazole—Urticaria—Formoterol—chronic obstructive pulmonary disease	6.24e-05	0.000389	CcSEcCtD
Aripiprazole—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	6.21e-05	0.000387	CcSEcCtD
Aripiprazole—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	6.21e-05	0.000387	CcSEcCtD
Aripiprazole—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	6.21e-05	0.000387	CcSEcCtD
Aripiprazole—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	6.21e-05	0.000387	CcSEcCtD
Aripiprazole—Affect lability—Prednisone—chronic obstructive pulmonary disease	6.19e-05	0.000386	CcSEcCtD
Aripiprazole—Vomiting—Tiotropium—chronic obstructive pulmonary disease	6.19e-05	0.000386	CcSEcCtD
Aripiprazole—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	6.15e-05	0.000383	CcSEcCtD
Aripiprazole—Rash—Tiotropium—chronic obstructive pulmonary disease	6.14e-05	0.000383	CcSEcCtD
Aripiprazole—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	6.13e-05	0.000382	CcSEcCtD
Aripiprazole—Nausea—Aminophylline—chronic obstructive pulmonary disease	6.13e-05	0.000382	CcSEcCtD
Aripiprazole—Urticaria—Montelukast—chronic obstructive pulmonary disease	6.12e-05	0.000381	CcSEcCtD
Aripiprazole—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	6.12e-05	0.000381	CcSEcCtD
Aripiprazole—Headache—Tiotropium—chronic obstructive pulmonary disease	6.1e-05	0.00038	CcSEcCtD
Aripiprazole—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	6.1e-05	0.00038	CcSEcCtD
Aripiprazole—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	6.09e-05	0.000379	CcSEcCtD
Aripiprazole—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	6.09e-05	0.000379	CcSEcCtD
Aripiprazole—Face oedema—Prednisone—chronic obstructive pulmonary disease	6.08e-05	0.000379	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	6.07e-05	0.000378	CcSEcCtD
Aripiprazole—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	6.02e-05	0.000375	CcSEcCtD
Aripiprazole—Irritability—Prednisone—chronic obstructive pulmonary disease	6.01e-05	0.000374	CcSEcCtD
Aripiprazole—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	5.99e-05	0.000373	CcSEcCtD
Aripiprazole—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	5.98e-05	0.000373	CcSEcCtD
Aripiprazole—Mood swings—Prednisone—chronic obstructive pulmonary disease	5.96e-05	0.000372	CcSEcCtD
Aripiprazole—Urticaria—Salbutamol—chronic obstructive pulmonary disease	5.9e-05	0.000367	CcSEcCtD
Aripiprazole—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	5.87e-05	0.000366	CcSEcCtD
Aripiprazole—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	5.87e-05	0.000366	CcSEcCtD
Aripiprazole—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	5.79e-05	0.000361	CcSEcCtD
Aripiprazole—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	5.79e-05	0.000361	CcSEcCtD
Aripiprazole—Nausea—Tiotropium—chronic obstructive pulmonary disease	5.78e-05	0.000361	CcSEcCtD
Aripiprazole—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	5.77e-05	0.00036	CcSEcCtD
Aripiprazole—Dry skin—Prednisone—chronic obstructive pulmonary disease	5.77e-05	0.00036	CcSEcCtD
Aripiprazole—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	5.73e-05	0.000357	CcSEcCtD
Aripiprazole—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	5.67e-05	0.000354	CcSEcCtD
Aripiprazole—Asthenia—Arformoterol—chronic obstructive pulmonary disease	5.64e-05	0.000351	CcSEcCtD
Aripiprazole—Asthenia—Formoterol—chronic obstructive pulmonary disease	5.64e-05	0.000351	CcSEcCtD
Aripiprazole—Pruritus—Arformoterol—chronic obstructive pulmonary disease	5.56e-05	0.000347	CcSEcCtD
Aripiprazole—Pruritus—Formoterol—chronic obstructive pulmonary disease	5.56e-05	0.000347	CcSEcCtD
Aripiprazole—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	5.55e-05	0.000346	CcSEcCtD
Aripiprazole—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	5.55e-05	0.000346	CcSEcCtD
Aripiprazole—Asthenia—Montelukast—chronic obstructive pulmonary disease	5.52e-05	0.000344	CcSEcCtD
Aripiprazole—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	5.48e-05	0.000341	CcSEcCtD
Aripiprazole—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	5.47e-05	0.000341	CcSEcCtD
Aripiprazole—Pruritus—Montelukast—chronic obstructive pulmonary disease	5.45e-05	0.000339	CcSEcCtD
Aripiprazole—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	5.38e-05	0.000335	CcSEcCtD
Aripiprazole—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	5.38e-05	0.000335	CcSEcCtD
Aripiprazole—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	5.33e-05	0.000332	CcSEcCtD
Aripiprazole—Asthenia—Salbutamol—chronic obstructive pulmonary disease	5.32e-05	0.000332	CcSEcCtD
Aripiprazole—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	5.27e-05	0.000328	CcSEcCtD
Aripiprazole—Pruritus—Salbutamol—chronic obstructive pulmonary disease	5.25e-05	0.000327	CcSEcCtD
Aripiprazole—Erythema—Prednisolone—chronic obstructive pulmonary disease	5.22e-05	0.000325	CcSEcCtD
Aripiprazole—Dizziness—Formoterol—chronic obstructive pulmonary disease	5.2e-05	0.000324	CcSEcCtD
Aripiprazole—Dizziness—Arformoterol—chronic obstructive pulmonary disease	5.2e-05	0.000324	CcSEcCtD
Aripiprazole—Dizziness—Montelukast—chronic obstructive pulmonary disease	5.09e-05	0.000317	CcSEcCtD
Aripiprazole—Neutropenia—Prednisone—chronic obstructive pulmonary disease	5.09e-05	0.000317	CcSEcCtD
Aripiprazole—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	5.08e-05	0.000316	CcSEcCtD
Aripiprazole—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	5.01e-05	0.000312	CcSEcCtD
Aripiprazole—Vomiting—Arformoterol—chronic obstructive pulmonary disease	5e-05	0.000311	CcSEcCtD
Aripiprazole—Vomiting—Formoterol—chronic obstructive pulmonary disease	5e-05	0.000311	CcSEcCtD
Aripiprazole—Rash—Formoterol—chronic obstructive pulmonary disease	4.96e-05	0.000309	CcSEcCtD
Aripiprazole—Rash—Arformoterol—chronic obstructive pulmonary disease	4.96e-05	0.000309	CcSEcCtD
Aripiprazole—Dermatitis—Formoterol—chronic obstructive pulmonary disease	4.95e-05	0.000309	CcSEcCtD
Aripiprazole—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	4.95e-05	0.000309	CcSEcCtD
Aripiprazole—Weight increased—Prednisone—chronic obstructive pulmonary disease	4.95e-05	0.000309	CcSEcCtD
Aripiprazole—Headache—Formoterol—chronic obstructive pulmonary disease	4.92e-05	0.000307	CcSEcCtD
Aripiprazole—Headache—Arformoterol—chronic obstructive pulmonary disease	4.92e-05	0.000307	CcSEcCtD
Aripiprazole—Weight decreased—Prednisone—chronic obstructive pulmonary disease	4.92e-05	0.000307	CcSEcCtD
Aripiprazole—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	4.92e-05	0.000306	CcSEcCtD
Aripiprazole—Dizziness—Salbutamol—chronic obstructive pulmonary disease	4.91e-05	0.000306	CcSEcCtD
Aripiprazole—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	4.91e-05	0.000306	CcSEcCtD
Aripiprazole—Vomiting—Montelukast—chronic obstructive pulmonary disease	4.89e-05	0.000305	CcSEcCtD
Aripiprazole—Rash—Montelukast—chronic obstructive pulmonary disease	4.85e-05	0.000303	CcSEcCtD
Aripiprazole—Dermatitis—Montelukast—chronic obstructive pulmonary disease	4.85e-05	0.000302	CcSEcCtD
Aripiprazole—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	4.84e-05	0.000302	CcSEcCtD
Aripiprazole—Depression—Prednisone—chronic obstructive pulmonary disease	4.84e-05	0.000301	CcSEcCtD
Aripiprazole—Headache—Montelukast—chronic obstructive pulmonary disease	4.82e-05	0.000301	CcSEcCtD
Aripiprazole—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	4.78e-05	0.000298	CcSEcCtD
Aripiprazole—Angioedema—Prednisolone—chronic obstructive pulmonary disease	4.77e-05	0.000297	CcSEcCtD
Aripiprazole—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	4.75e-05	0.000296	CcSEcCtD
Aripiprazole—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	4.75e-05	0.000296	CcSEcCtD
Aripiprazole—Vomiting—Salbutamol—chronic obstructive pulmonary disease	4.72e-05	0.000294	CcSEcCtD
Aripiprazole—Malaise—Prednisolone—chronic obstructive pulmonary disease	4.7e-05	0.000293	CcSEcCtD
Aripiprazole—Vertigo—Prednisolone—chronic obstructive pulmonary disease	4.69e-05	0.000292	CcSEcCtD
Aripiprazole—Rash—Salbutamol—chronic obstructive pulmonary disease	4.68e-05	0.000292	CcSEcCtD
Aripiprazole—Syncope—Prednisolone—chronic obstructive pulmonary disease	4.68e-05	0.000292	CcSEcCtD
Aripiprazole—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	4.67e-05	0.000291	CcSEcCtD
Aripiprazole—Nausea—Formoterol—chronic obstructive pulmonary disease	4.67e-05	0.000291	CcSEcCtD
Aripiprazole—Nausea—Arformoterol—chronic obstructive pulmonary disease	4.67e-05	0.000291	CcSEcCtD
Aripiprazole—Headache—Salbutamol—chronic obstructive pulmonary disease	4.65e-05	0.00029	CcSEcCtD
Aripiprazole—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	4.58e-05	0.000286	CcSEcCtD
Aripiprazole—Nausea—Montelukast—chronic obstructive pulmonary disease	4.57e-05	0.000285	CcSEcCtD
Aripiprazole—Convulsion—Prednisolone—chronic obstructive pulmonary disease	4.52e-05	0.000282	CcSEcCtD
Aripiprazole—Hypertension—Prednisolone—chronic obstructive pulmonary disease	4.5e-05	0.000281	CcSEcCtD
Aripiprazole—Bradycardia—Prednisone—chronic obstructive pulmonary disease	4.43e-05	0.000276	CcSEcCtD
Aripiprazole—Nausea—Salbutamol—chronic obstructive pulmonary disease	4.41e-05	0.000275	CcSEcCtD
Aripiprazole—Discomfort—Prednisolone—chronic obstructive pulmonary disease	4.39e-05	0.000273	CcSEcCtD
Aripiprazole—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	4.38e-05	0.000273	CcSEcCtD
Aripiprazole—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	4.35e-05	0.000271	CcSEcCtD
Aripiprazole—Hallucination—Prednisone—chronic obstructive pulmonary disease	4.33e-05	0.00027	CcSEcCtD
Aripiprazole—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	4.28e-05	0.000267	CcSEcCtD
Aripiprazole—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	4.26e-05	0.000265	CcSEcCtD
Aripiprazole—Oedema—Prednisolone—chronic obstructive pulmonary disease	4.26e-05	0.000265	CcSEcCtD
Aripiprazole—Shock—Prednisolone—chronic obstructive pulmonary disease	4.19e-05	0.000261	CcSEcCtD
Aripiprazole—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	4.15e-05	0.000259	CcSEcCtD
Aripiprazole—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	4.11e-05	0.000256	CcSEcCtD
Aripiprazole—Eye disorder—Prednisone—chronic obstructive pulmonary disease	4.07e-05	0.000254	CcSEcCtD
Aripiprazole—Flushing—Prednisone—chronic obstructive pulmonary disease	4.04e-05	0.000252	CcSEcCtD
Aripiprazole—Angiopathy—Prednisone—chronic obstructive pulmonary disease	3.95e-05	0.000246	CcSEcCtD
Aripiprazole—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	3.93e-05	0.000245	CcSEcCtD
Aripiprazole—Insomnia—Prednisolone—chronic obstructive pulmonary disease	3.85e-05	0.00024	CcSEcCtD
Aripiprazole—Alopecia—Prednisone—chronic obstructive pulmonary disease	3.85e-05	0.00024	CcSEcCtD
Aripiprazole—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	3.82e-05	0.000238	CcSEcCtD
Aripiprazole—Mental disorder—Prednisone—chronic obstructive pulmonary disease	3.81e-05	0.000238	CcSEcCtD
Aripiprazole—Malnutrition—Prednisone—chronic obstructive pulmonary disease	3.79e-05	0.000236	CcSEcCtD
Aripiprazole—Erythema—Prednisone—chronic obstructive pulmonary disease	3.79e-05	0.000236	CcSEcCtD
Aripiprazole—Pain—Prednisolone—chronic obstructive pulmonary disease	3.64e-05	0.000227	CcSEcCtD
Aripiprazole—Vision blurred—Prednisone—chronic obstructive pulmonary disease	3.57e-05	0.000223	CcSEcCtD
Aripiprazole—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	3.52e-05	0.000219	CcSEcCtD
Aripiprazole—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	3.51e-05	0.000219	CcSEcCtD
Aripiprazole—Anaemia—Prednisone—chronic obstructive pulmonary disease	3.5e-05	0.000218	CcSEcCtD
Aripiprazole—Agitation—Prednisone—chronic obstructive pulmonary disease	3.48e-05	0.000217	CcSEcCtD
Aripiprazole—Angioedema—Prednisone—chronic obstructive pulmonary disease	3.46e-05	0.000216	CcSEcCtD
Aripiprazole—Malaise—Prednisone—chronic obstructive pulmonary disease	3.42e-05	0.000213	CcSEcCtD
Aripiprazole—Vertigo—Prednisone—chronic obstructive pulmonary disease	3.4e-05	0.000212	CcSEcCtD
Aripiprazole—Syncope—Prednisone—chronic obstructive pulmonary disease	3.4e-05	0.000212	CcSEcCtD
Aripiprazole—Urticaria—Prednisolone—chronic obstructive pulmonary disease	3.38e-05	0.000211	CcSEcCtD
Aripiprazole—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	3.33e-05	0.000208	CcSEcCtD
Aripiprazole—Convulsion—Prednisone—chronic obstructive pulmonary disease	3.28e-05	0.000205	CcSEcCtD
Aripiprazole—Hypertension—Prednisone—chronic obstructive pulmonary disease	3.27e-05	0.000204	CcSEcCtD
Aripiprazole—Arthralgia—Prednisone—chronic obstructive pulmonary disease	3.23e-05	0.000201	CcSEcCtD
Aripiprazole—Myalgia—Prednisone—chronic obstructive pulmonary disease	3.23e-05	0.000201	CcSEcCtD
Aripiprazole—Anxiety—Prednisone—chronic obstructive pulmonary disease	3.22e-05	0.0002	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	3.2e-05	0.0002	CcSEcCtD
Aripiprazole—Discomfort—Prednisone—chronic obstructive pulmonary disease	3.19e-05	0.000199	CcSEcCtD
Aripiprazole—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	3.14e-05	0.000195	CcSEcCtD
Aripiprazole—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	3.09e-05	0.000193	CcSEcCtD
Aripiprazole—Oedema—Prednisone—chronic obstructive pulmonary disease	3.09e-05	0.000193	CcSEcCtD
Aripiprazole—Infection—Prednisone—chronic obstructive pulmonary disease	3.07e-05	0.000192	CcSEcCtD
Aripiprazole—Shock—Prednisone—chronic obstructive pulmonary disease	3.04e-05	0.00019	CcSEcCtD
Aripiprazole—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	3.03e-05	0.000189	CcSEcCtD
Aripiprazole—Tachycardia—Prednisone—chronic obstructive pulmonary disease	3.02e-05	0.000188	CcSEcCtD
Aripiprazole—Skin disorder—Prednisone—chronic obstructive pulmonary disease	3e-05	0.000187	CcSEcCtD
Aripiprazole—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	2.99e-05	0.000186	CcSEcCtD
Aripiprazole—Anorexia—Prednisone—chronic obstructive pulmonary disease	2.95e-05	0.000184	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	2.82e-05	0.000176	CcSEcCtD
Aripiprazole—Dizziness—Prednisolone—chronic obstructive pulmonary disease	2.81e-05	0.000175	CcSEcCtD
Aripiprazole—Insomnia—Prednisone—chronic obstructive pulmonary disease	2.8e-05	0.000174	CcSEcCtD
Aripiprazole—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	2.78e-05	0.000173	CcSEcCtD
Aripiprazole—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	2.72e-05	0.00017	CcSEcCtD
Aripiprazole—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	2.69e-05	0.000168	CcSEcCtD
Aripiprazole—Rash—Prednisolone—chronic obstructive pulmonary disease	2.68e-05	0.000167	CcSEcCtD
Aripiprazole—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	2.68e-05	0.000167	CcSEcCtD
Aripiprazole—Fatigue—Prednisone—chronic obstructive pulmonary disease	2.67e-05	0.000166	CcSEcCtD
Aripiprazole—Headache—Prednisolone—chronic obstructive pulmonary disease	2.67e-05	0.000166	CcSEcCtD
Aripiprazole—Constipation—Prednisone—chronic obstructive pulmonary disease	2.65e-05	0.000165	CcSEcCtD
Aripiprazole—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	2.55e-05	0.000159	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	2.53e-05	0.000158	CcSEcCtD
Aripiprazole—Nausea—Prednisolone—chronic obstructive pulmonary disease	2.53e-05	0.000158	CcSEcCtD
Aripiprazole—Urticaria—Prednisone—chronic obstructive pulmonary disease	2.46e-05	0.000153	CcSEcCtD
Aripiprazole—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	2.45e-05	0.000152	CcSEcCtD
Aripiprazole—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	2.45e-05	0.000152	CcSEcCtD
Aripiprazole—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	2.28e-05	0.000142	CcSEcCtD
Aripiprazole—Asthenia—Prednisone—chronic obstructive pulmonary disease	2.22e-05	0.000138	CcSEcCtD
Aripiprazole—Pruritus—Prednisone—chronic obstructive pulmonary disease	2.19e-05	0.000136	CcSEcCtD
Aripiprazole—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	2.12e-05	0.000132	CcSEcCtD
Aripiprazole—Dizziness—Prednisone—chronic obstructive pulmonary disease	2.05e-05	0.000127	CcSEcCtD
Aripiprazole—Vomiting—Prednisone—chronic obstructive pulmonary disease	1.97e-05	0.000123	CcSEcCtD
Aripiprazole—Rash—Prednisone—chronic obstructive pulmonary disease	1.95e-05	0.000122	CcSEcCtD
Aripiprazole—Dermatitis—Prednisone—chronic obstructive pulmonary disease	1.95e-05	0.000121	CcSEcCtD
Aripiprazole—Headache—Prednisone—chronic obstructive pulmonary disease	1.94e-05	0.000121	CcSEcCtD
Aripiprazole—Nausea—Prednisone—chronic obstructive pulmonary disease	1.84e-05	0.000115	CcSEcCtD
Aripiprazole—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.87e-06	5.23e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.86e-06	5.22e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.84e-06	5.2e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.84e-06	5.19e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.84e-06	5.19e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.83e-06	5.19e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.83e-06	5.18e-05	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.81e-06	5.16e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.81e-06	5.15e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.81e-06	5.15e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—ALB—chronic obstructive pulmonary disease	3.79e-06	5.13e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.78e-06	5.11e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.76e-06	5.09e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.74e-06	5.05e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.73e-06	5.05e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.72e-06	5.03e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.71e-06	5.02e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.7e-06	5.01e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.7e-06	5.01e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.69e-06	4.99e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.68e-06	4.98e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.67e-06	4.96e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.67e-06	4.96e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.65e-06	4.94e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.65e-06	4.93e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—NOS3—chronic obstructive pulmonary disease	3.63e-06	4.91e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.62e-06	4.9e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.61e-06	4.89e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.61e-06	4.88e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.59e-06	4.86e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	3.57e-06	4.83e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.54e-06	4.79e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.54e-06	4.79e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.53e-06	4.78e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.52e-06	4.77e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.52e-06	4.76e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.5e-06	4.74e-05	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.49e-06	4.72e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	3.48e-06	4.71e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.47e-06	4.7e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.47e-06	4.69e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.45e-06	4.66e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.44e-06	4.66e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.43e-06	4.64e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.43e-06	4.64e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.42e-06	4.63e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.41e-06	4.62e-05	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.37e-06	4.56e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.37e-06	4.56e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.36e-06	4.54e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.35e-06	4.53e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.35e-06	4.53e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.34e-06	4.52e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.34e-06	4.51e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.33e-06	4.5e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	3.33e-06	4.5e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.31e-06	4.47e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.3e-06	4.46e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.3e-06	4.46e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.29e-06	4.45e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.29e-06	4.44e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.26e-06	4.41e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	3.26e-06	4.41e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.26e-06	4.41e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.25e-06	4.4e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.25e-06	4.4e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.21e-06	4.33e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.2e-06	4.33e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	3.19e-06	4.31e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.19e-06	4.31e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.18e-06	4.3e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.16e-06	4.28e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.16e-06	4.27e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.15e-06	4.26e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.15e-06	4.26e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.14e-06	4.25e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.14e-06	4.25e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.14e-06	4.24e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.13e-06	4.23e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.12e-06	4.22e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.11e-06	4.21e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.11e-06	4.21e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.1e-06	4.2e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.1e-06	4.19e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.1e-06	4.19e-05	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.09e-06	4.18e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.08e-06	4.16e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.07e-06	4.16e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.06e-06	4.14e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.06e-06	4.13e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.05e-06	4.13e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	3.05e-06	4.13e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.04e-06	4.12e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.04e-06	4.11e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.03e-06	4.1e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.03e-06	4.09e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.01e-06	4.08e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3e-06	4.06e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3e-06	4.06e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3e-06	4.05e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.99e-06	4.05e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.99e-06	4.04e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.99e-06	4.04e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.97e-06	4.02e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.97e-06	4.02e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.97e-06	4.01e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.97e-06	4.01e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.94e-06	3.98e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.93e-06	3.96e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.93e-06	3.96e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.92e-06	3.94e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.89e-06	3.91e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.89e-06	3.91e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.86e-06	3.87e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.85e-06	3.85e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.84e-06	3.84e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.83e-06	3.83e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.83e-06	3.82e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.8e-06	3.79e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.78e-06	3.77e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.76e-06	3.73e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.75e-06	3.72e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.72e-06	3.68e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.71e-06	3.67e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.71e-06	3.66e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.71e-06	3.66e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.7e-06	3.65e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.69e-06	3.64e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.69e-06	3.63e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.67e-06	3.61e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.67e-06	3.61e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.67e-06	3.6e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.66e-06	3.59e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.64e-06	3.58e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.64e-06	3.56e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.62e-06	3.55e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.61e-06	3.52e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.6e-06	3.52e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.59e-06	3.5e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.58e-06	3.49e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.58e-06	3.48e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.57e-06	3.47e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.56e-06	3.46e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.55e-06	3.45e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.54e-06	3.43e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.53e-06	3.43e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.53e-06	3.42e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.53e-06	3.42e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.5e-06	3.39e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.5e-06	3.37e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.49e-06	3.37e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.47e-06	3.34e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.47e-06	3.34e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.47e-06	3.34e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.46e-06	3.32e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.46e-06	3.32e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.45e-06	3.31e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.45e-06	3.31e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.44e-06	3.3e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.43e-06	3.29e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.43e-06	3.29e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.43e-06	3.28e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.41e-06	3.26e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	2.41e-06	3.26e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.4e-06	3.25e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.4e-06	3.25e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.38e-06	3.22e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.38e-06	3.22e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.38e-06	3.22e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.38e-06	3.22e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.37e-06	3.2e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.35e-06	3.18e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.35e-06	3.18e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.34e-06	3.17e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.33e-06	3.15e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.32e-06	3.13e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.3e-06	3.11e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.3e-06	3.11e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.3e-06	3.11e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.28e-06	3.09e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.28e-06	3.08e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	2.27e-06	3.07e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.27e-06	3.07e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.25e-06	3.04e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.24e-06	3.03e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.24e-06	3.03e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.23e-06	3.02e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.23e-06	3.02e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.22e-06	3.01e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.21e-06	2.99e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.2e-06	2.98e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.2e-06	2.98e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.19e-06	2.97e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.19e-06	2.96e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.19e-06	2.96e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.18e-06	2.95e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.18e-06	2.94e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.17e-06	2.93e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.16e-06	2.93e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.16e-06	2.92e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.15e-06	2.91e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.06e-06	2.78e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.05e-06	2.78e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.03e-06	2.74e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.02e-06	2.74e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.02e-06	2.73e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.02e-06	2.73e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.02e-06	2.73e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.01e-06	2.72e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.01e-06	2.71e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.01e-06	2.71e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2e-06	2.7e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.99e-06	2.69e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.98e-06	2.68e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.98e-06	2.68e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.98e-06	2.68e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.97e-06	2.67e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.97e-06	2.66e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.95e-06	2.63e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.94e-06	2.63e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.93e-06	2.61e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.92e-06	2.59e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.87e-06	2.52e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.85e-06	2.5e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.84e-06	2.49e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.84e-06	2.48e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.83e-06	2.47e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.81e-06	2.44e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.77e-06	2.39e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.76e-06	2.37e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.71e-06	2.31e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.69e-06	2.29e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.68e-06	2.27e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.67e-06	2.25e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.66e-06	2.25e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.66e-06	2.24e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.65e-06	2.23e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.64e-06	2.21e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.63e-06	2.21e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.55e-06	2.1e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.52e-06	2.06e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.52e-06	2.06e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.52e-06	2.05e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.52e-06	2.05e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.51e-06	2.04e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.5e-06	2.02e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.49e-06	2.02e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.48e-06	2.01e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.42e-06	1.92e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.39e-06	1.88e-05	CbGpPWpGaD
